skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

Candida

(Last updated: September 1, 2014; last reviewed: September 1, 2014)

Mucocutaneous Candidiasis
Member Financial Disclosure
Company Relationship
Lionakis, Michail* National Institutes of Health None N/A
Ostrosky-Zeichner, Luis University of Texas Houston Astellas Advisory Board, Consultant, Research Support
Cape Cod Assoc. Research Support
Merck Advisory Board, Consultant, Research Support, Speaker’s Bureau
Pfizer Advisory Board, Consultant, Research Support, Speaker’s Bureau
T2 Biosystems Research Support
Revankar, Sanjay
Wayne State University School of Medicine Astellas Research Support
Merck Research Support
Optimer Consultant
T2 Biosystems Research Support
Sobel, Jack Wayne State University School of Medicine Astellas Honoraria, Speaker’s Bureau
Vazquez, Jose Henry Ford Hospital Astellas Honoraria, Research Support, Speaker’s Bureau
Forest Advisory Board, Honoraria, Speaker’s Bureau
Merck Honoraria, Research Support, Speaker’s Bureau
Pfizer Honoraria, Research Support, Speaker’s Bureau
Strativa Honoraria, Speaker’s Bureau
* Group lead

Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from September 1, 2012, through September 1, 2014.

Back to Top